Published in PLoS One on February 16, 2009
Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature (2010) 5.84
Microbial engineering for the production of advanced biofuels. Nature (2012) 3.60
Natural products version 2.0: connecting genes to molecules. J Am Chem Soc (2010) 3.06
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A (2012) 2.06
Identification and microbial production of a terpene-based advanced biofuel. Nat Commun (2011) 1.65
The global pipeline of new medicines for the control and elimination of malaria. Malar J (2012) 1.57
Designing and engineering evolutionary robust genetic circuits. J Biol Eng (2010) 1.37
Next generation biofuel engineering in prokaryotes. Curr Opin Chem Biol (2013) 1.23
A high-throughput approach to identify genomic variants of bacterial metabolite producers at the single-cell level. Genome Biol (2012) 1.18
Triterpenoid biosynthesis and engineering in plants. Front Plant Sci (2011) 1.14
Enhancing isoprene production by genetic modification of the 1-deoxy-d-xylulose-5-phosphate pathway in Bacillus subtilis. Appl Environ Microbiol (2011) 1.08
Building better scientists through cross-disciplinary collaboration in synthetic biology: A report from the Genome Consortium for Active Teaching Workshop 2010. CBE Life Sci Educ (2010) 1.08
HipA-triggered growth arrest and β-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis. J Bacteriol (2013) 1.03
Methylerythritol phosphate pathway of isoprenoid biosynthesis. Annu Rev Biochem (2013) 1.02
Protocols for implementing an Escherichia coli based TX-TL cell-free expression system for synthetic biology. J Vis Exp (2013) 0.98
The metabolic potential of Escherichia coli BL21 in defined and rich medium. Microb Cell Fact (2014) 0.97
An insight into the role of phosphotransacetylase (pta) and the acetate/acetyl-CoA node in Escherichia coli. Microb Cell Fact (2009) 0.97
Engineering Escherichia coli for succinate production from hemicellulose via consolidated bioprocessing. Microb Cell Fact (2012) 0.95
Towards a carbon-negative sustainable bio-based economy. Front Plant Sci (2013) 0.95
Engineering microbial chemical factories to produce renewable "biomonomers". Front Microbiol (2012) 0.92
Genome-wide analytical approaches for reverse metabolic engineering of industrially relevant phenotypes in yeast. FEMS Yeast Res (2012) 0.92
A platform pathway for production of 3-hydroxyacids provides a biosynthetic route to 3-hydroxy-γ-butyrolactone. Nat Commun (2013) 0.88
Synthetic biology: putting synthesis into biology. Wiley Interdiscip Rev Syst Biol Med (2010) 0.87
High-level diterpene production by transient expression in Nicotiana benthamiana. Plant Methods (2013) 0.86
Metabolic engineering of strains: from industrial-scale to lab-scale chemical production. J Ind Microbiol Biotechnol (2014) 0.85
Combinatorial engineering of 1-deoxy-D-xylulose 5-phosphate pathway using cross-lapping in vitro assembly (CLIVA) method. PLoS One (2013) 0.85
Combining genotype improvement and statistical media optimization for isoprenoid production in E. coli. PLoS One (2013) 0.84
Microbial Synthesis of the Forskolin Precursor Manoyl Oxide in an Enantiomerically Pure Form. Appl Environ Microbiol (2014) 0.83
The PLOS ONE synthetic biology collection: six years and counting. PLoS One (2012) 0.83
In silico profiling of Escherichia coli and Saccharomyces cerevisiae as terpenoid factories. Microb Cell Fact (2013) 0.82
Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites. J Nat Med (2016) 0.81
Optimization of genetic transformation of Artemisia annua L. Using Agrobacterium for Artemisinin production. Pharmacogn Mag (2014) 0.81
Retinoid production using metabolically engineered Escherichia coli with a two-phase culture system. Microb Cell Fact (2011) 0.81
Metabolic engineering for the high-yield production of isoprenoid-based C₅ alcohols in E. coli. Sci Rep (2015) 0.80
Directed pathway evolution of the glyoxylate shunt in Escherichia coli for improved aerobic succinate production from glycerol. J Ind Microbiol Biotechnol (2013) 0.80
Engineering microbial cells for the biosynthesis of natural compounds of pharmaceutical significance. Biomed Res Int (2013) 0.80
De novo production of the monoterpenoid geranic acid by metabolically engineered Pseudomonas putida. Microb Cell Fact (2014) 0.80
Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production. Front Plant Sci (2016) 0.78
Stable heterologous expression of biologically active terpenoids in green plant cells. Front Plant Sci (2015) 0.78
Transgenic approach to increase artemisinin content in Artemisia annua L. Plant Cell Rep (2014) 0.78
Optimising Terpene Synthesis with Flow Biocatalysis. European J Org Chem (2017) 0.77
Toward biosynthetic design and implementation of Escherichia coli-derived paclitaxel and other heterologous polyisoprene compounds. Appl Environ Microbiol (2012) 0.77
Coupling gene regulatory patterns to bioprocess conditions to optimize synthetic metabolic modules for improved sesquiterpene production in yeast. Biotechnol Biofuels (2017) 0.77
Escherichia coli deletion mutants illuminate trade-offs between growth rate and flux through a foreign anabolic pathway. PLoS One (2014) 0.77
Evolution, ecology and the engineered organism: lessons for synthetic biology. Genome Biol (2009) 0.77
Accessing Nature's diversity through metabolic engineering and synthetic biology. F1000Res (2016) 0.76
Transcriptome landscape of Synechococcus elongatus PCC 7942 for nitrogen starvation responses using RNA-seq. Sci Rep (2016) 0.75
An enzymatic platform for the synthesis of isoprenoid precursors. PLoS One (2014) 0.75
Metabolic engineering of Bacillus subtilis for terpenoid production. Appl Microbiol Biotechnol (2015) 0.75
An in-silico insight into the substrate binding characteristics of the active site of amorpha-4, 11-diene synthase, a key enzyme in artemisinin biosynthesis. J Mol Model (2017) 0.75
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature (2006) 13.86
Qinghaosu (artemisinin): the price of success. Science (2008) 8.25
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol (2003) 6.74
Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase. Biotechniques (2001) 3.31
Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol (2005) 2.95
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng (2006) 2.31
Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Am J Trop Med Hyg (2007) 2.15
Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. FEBS Lett (2006) 1.92
Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metab Eng (2008) 1.81
Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol (2007) 1.79
Simple fed-batch technique for high cell density cultivation of Escherichia coli. J Biotechnol (1995) 1.65
High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol Bioeng (2006) 1.53
Application of functional genomics to pathway optimization for increased isoprenoid production. Appl Environ Microbiol (2008) 1.38
Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus. J Bacteriol (2000) 1.34
Productive and abortive initiation of transcription in vitro at the lac UV5 promoter. Biochemistry (1980) 1.29
Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnol Bioeng (2004) 1.10
Enterococcus faecalis acetoacetyl-coenzyme A thiolase/3-hydroxy-3-methylglutaryl-coenzyme A reductase, a dual-function protein of isopentenyl diphosphate biosynthesis. J Bacteriol (2002) 1.09
Recombinant protein expression in high cell density fed-batch cultures of Escherichia coli. Biotechnology (N Y) (1992) 1.08
Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases. J Bacteriol (2004) 1.05
Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. J Biotechnol (2004) 1.03
Enterococcus faecalis 3-hydroxy-3-methylglutaryl coenzyme A synthase, an enzyme of isopentenyl diphosphate biosynthesis. J Bacteriol (2002) 1.02
High-cell-density cultivation of Escherichia coli. Curr Opin Biotechnol (1991) 0.99
Staphylococcus aureus 3-hydroxy-3-methylglutaryl-CoA synthase: crystal structure and mechanism. J Biol Chem (2004) 0.98
Production of mevalonate by a metabolically-engineered Escherichia coli. Biotechnol Lett (2004) 0.93
Effect of nitrogen limitation on the ergosterol production by fed-batch culture of Saccharomyces cerevisiae. J Biotechnol (2006) 0.93
Developing an industrial artemisinic acid fermentation process to support the cost-effective production of antimalarial artemisinin-based combination therapies. Biotechnol Prog (2009) 0.90
Nutrient regulation of epothilone biosynthesis in heterologous and native production strains. Appl Microbiol Biotechnol (2003) 0.81
Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature (2006) 13.86
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol (2003) 6.74
Microbial production of fatty-acid-derived fuels and chemicals from plant biomass. Nature (2010) 5.84
Synthetic protein scaffolds provide modular control over metabolic flux. Nat Biotechnol (2009) 4.11
Microbial engineering for the production of advanced biofuels. Nature (2012) 3.60
Designed divergent evolution of enzyme function. Nature (2006) 3.09
Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat Biotechnol (2006) 3.02
Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Curr Opin Biotechnol (2008) 2.80
Precise and reliable gene expression via standard transcription and translation initiation elements. Nat Methods (2013) 2.61
Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids. Nat Biotechnol (2012) 2.55
Production of isoprenoid pharmaceuticals by engineered microbes. Nat Chem Biol (2006) 2.35
Model-driven engineering of RNA devices to quantitatively program gene expression. Science (2011) 2.33
BglBricks: A flexible standard for biological part assembly. J Biol Eng (2010) 2.32
Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng (2006) 2.31
Metabolic engineering of Saccharomyces cerevisiae for the production of n-butanol. Microb Cell Fact (2008) 2.26
Biofuel alternatives to ethanol: pumping the microbial well. Trends Biotechnol (2008) 2.18
Microbially derived artemisinin: a biotechnology solution to the global problem of access to affordable antimalarial drugs. Am J Trop Med Hyg (2007) 2.15
Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A (2012) 2.06
Quantitative estimation of activity and quality for collections of functional genetic elements. Nat Methods (2013) 2.03
Biosynthesis of plant isoprenoids: perspectives for microbial engineering. Annu Rev Plant Biol (2009) 1.98
Engineering microbial biofuel tolerance and export using efflux pumps. Mol Syst Biol (2011) 1.96
Advanced biofuel production in microbes. Biotechnol J (2010) 1.94
Retrograde signaling by the plastidial metabolite MEcPP regulates expression of nuclear stress-response genes. Cell (2012) 1.87
Genes involved in long-chain alkene biosynthesis in Micrococcus luteus. Appl Environ Microbiol (2009) 1.87
Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metab Eng (2008) 1.81
Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol (2007) 1.79
j5 DNA assembly design automation software. ACS Synth Biol (2011) 1.78
Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coli. Proc Natl Acad Sci U S A (2011) 1.75
Functional genomic study of exogenous n-butanol stress in Escherichia coli. Appl Environ Microbiol (2010) 1.69
Salt stress in Desulfovibrio vulgaris Hildenborough: an integrated genomics approach. J Bacteriol (2006) 1.68
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol (2008) 1.68
Metabolic engineering for drug discovery and development. Nat Rev Drug Discov (2003) 1.67
Structure of a three-domain sesquiterpene synthase: a prospective target for advanced biofuels production. Structure (2011) 1.67
Identification and microbial production of a terpene-based advanced biofuel. Nat Commun (2011) 1.65
Metabolic engineering of microbial pathways for advanced biofuels production. Curr Opin Biotechnol (2011) 1.64
Metabolic engineering delivers next-generation biofuels. Nat Biotechnol (2008) 1.60
High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol Bioeng (2006) 1.53
Engineering static and dynamic control of synthetic pathways. Cell (2010) 1.52
Design and construction of a double inversion recombination switch for heritable sequential genetic memory. PLoS One (2008) 1.49
Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol (2007) 1.40
Pathway confirmation and flux analysis of central metabolic pathways in Desulfovibrio vulgaris hildenborough using gas chromatography-mass spectrometry and Fourier transform-ion cyclotron resonance mass spectrometry. J Bacteriol (2006) 1.40
Design, implementation and practice of JBEI-ICE: an open source biological part registry platform and tools. Nucleic Acids Res (2012) 1.39
Application of functional genomics to pathway optimization for increased isoprenoid production. Appl Environ Microbiol (2008) 1.38
Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids. Metab Eng (2006) 1.36
A tightly regulated inducible expression system utilizing the fim inversion recombination switch. Biotechnol Bioeng (2006) 1.35
Mono and diterpene production in Escherichia coli. Biotechnol Bioeng (2004) 1.35
Chemical synthesis using synthetic biology. Curr Opin Biotechnol (2009) 1.34
Membrane proteomics of phagosomes suggests a connection to autophagy. Proc Natl Acad Sci U S A (2008) 1.34
Rapid and reliable DNA assembly via ligase cycling reaction. ACS Synth Biol (2014) 1.31
Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production. Metab Eng (2013) 1.31
Metabolic flux elucidation for large-scale models using 13C labeled isotopes. Metab Eng (2007) 1.31
Modular engineering of L-tyrosine production in Escherichia coli. Appl Environ Microbiol (2011) 1.31
Advances in analysis of microbial metabolic fluxes via (13)C isotopic labeling. Mass Spectrom Rev (2009) 1.31
A propionate-inducible expression system for enteric bacteria. Appl Environ Microbiol (2005) 1.30
Enhancing fatty acid production by the expression of the regulatory transcription factor FadR. Metab Eng (2012) 1.30
Targeted proteomics for metabolic pathway optimization: application to terpene production. Metab Eng (2011) 1.29
Engineering dynamic pathway regulation using stress-response promoters. Nat Biotechnol (2013) 1.27
Directed evolution of AraC for improved compatibility of arabinose- and lactose-inducible promoters. Appl Environ Microbiol (2007) 1.26
Developing Aspergillus as a host for heterologous expression. Biotechnol Adv (2008) 1.26
Interactions between the Rhodobacter sphaeroides ECF sigma factor, sigma(E), and its anti-sigma factor, ChrR. J Mol Biol (2004) 1.23
Identification of genes affecting lycopene accumulation in Escherichia coli using a shot-gun method. Biotechnol Bioeng (2005) 1.23
Investigation of carbon metabolism in "Dehalococcoides ethenogenes" strain 195 by use of isotopomer and transcriptomic analyses. J Bacteriol (2009) 1.22
High-throughput metabolic engineering: advances in small-molecule screening and selection. Annu Rev Biochem (2010) 1.22
Shewanella oneidensis MR-1 fluxome under various oxygen conditions. Appl Environ Microbiol (2006) 1.22
Lutein accumulation in the absence of zeaxanthin restores nonphotochemical quenching in the Arabidopsis thaliana npq1 mutant. Plant Cell (2009) 1.20
Synthesis: A constructive debate. Nature (2012) 1.19
Catabolite repression of the propionate catabolic genes in Escherichia coli and Salmonella enterica: evidence for involvement of the cyclic AMP receptor protein. J Bacteriol (2005) 1.19
Process design for microbial plastic factories: metabolic engineering of polyhydroxyalkanoates. Curr Opin Biotechnol (2003) 1.18
Anaerobic central metabolic pathways in Shewanella oneidensis MR-1 reinterpreted in the light of isotopic metabolite labeling. J Bacteriol (2006) 1.17
Engineering of bacterial methyl ketone synthesis for biofuels. Appl Environ Microbiol (2011) 1.16
Importance of systems biology in engineering microbes for biofuel production. Curr Opin Biotechnol (2008) 1.16
Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol (2006) 1.15
Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotechnol Bioeng (2008) 1.15
Combinatorial expression of bacterial whole mevalonate pathway for the production of beta-carotene in E. coli. J Biotechnol (2009) 1.15
Transcription factor-based screens and synthetic selections for microbial small-molecule biosynthesis. ACS Synth Biol (2012) 1.15
Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate. Biotechnol Bioeng (2006) 1.14
Cell-wide responses to low-oxygen exposure in Desulfovibrio vulgaris Hildenborough. J Bacteriol (2007) 1.14
Polyphosphate kinase from activated sludge performing enhanced biological phosphorus removal. Appl Environ Microbiol (2002) 1.13
Engineering cotton (+)-delta-cadinene synthase to an altered function: germacrene D-4-ol synthase. Chem Biol (2006) 1.12
Three members of the Arabidopsis glycosyltransferase family 8 are xylan glucuronosyltransferases. Plant Physiol (2012) 1.10
A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). ACS Chem Biol (2009) 1.10
Global transcriptional, physiological, and metabolite analyses of the responses of Desulfovibrio vulgaris hildenborough to salt adaptation. Appl Environ Microbiol (2009) 1.10
XAX1 from glycosyltransferase family 61 mediates xylosyltransfer to rice xylan. Proc Natl Acad Sci U S A (2012) 1.09
Study of nitrate stress in Desulfovibrio vulgaris Hildenborough using iTRAQ proteomics. Brief Funct Genomic Proteomic (2006) 1.09